Jump to content

Template:Further points for assessing the study: Difference between revisions

From CAMIH
← Older edit
No edit summary
No edit summary
 
(3 intermediate revisions by 2 users not shown)
Line 3: Line 3:
</noinclude><includeonly>
</noinclude><includeonly>
==Sample==
==Sample==
{| class="wikitable" style="width:75%;"
{| class="wikitable" style="width:100%;"
|-
|-
! width=50% style="text-align:left;" | Power analysis performed
! width=70% style="text-align:left;" | Power analysis performed
| style="text-align:center;" | [[power analysis performed::{{{power analysis performed|}}}]]
| style="text-align:left;" | [[power analysis performed::{{{power analysis performed|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Sample size corresponds to power analysis
! style="text-align:left; text-indent:3em;" | - Sample size corresponds to power analysis
| style="text-align:center;" | [[Sample size corresponds to power analysis::{{{Sample size corresponds to power analysis|}}}]]
| style="text-align:left;" | [[Sample size corresponds to power analysis::{{{Sample size corresponds to power analysis|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis  
! style="text-align:left; text-indent:3em;" | - Reasons for insufficient sample size based on power analysis  
| style="text-align:center; white-space: pre-wrap;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]]
| style="text-align:left;" | [[Reasons given for samples being too small according to power analysis::{{{Reasons given for samples being too small according to power analysis|}}}]]
|-
|-
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm)
! style="text-align:left;" | If no power analysis performed: at least moderate sample size (n >= 30 per arm)
| style="text-align:center;" | [[Samples sufficiently large::{{{Samples sufficiently large|}}}]]
| style="text-align:left;" | [[Samples sufficiently large::{{{Samples sufficiently large|}}}]]
|-
|-
! style="text-align:left;" | Ethnicity mentioned  
! style="text-align:left;" | Ethnicity mentioned  
| style="text-align:center;" | [[Ethnicity mentioned::{{{Ethnicity mentioned|}}}]]
| style="text-align:left;" | [[Ethnicity mentioned::{{{Ethnicity mentioned|}}}]]
|}
|}
==Alternative Explanation==
==Alternative Explanation==
{| class="wikitable" style="width:75%;"
{| class="wikitable" style="width:100%;"
|-
|-
! width=50% style="text-align:left;" | Other explanations for an effect besides the investigated intervention
! width=30% style="text-align:left;" | Other explanations for an effect besides the investigated intervention
| style="text-align:center;" | [[Other explanations for an effect besides the investigated intervention::{{{Other explanations for an effect besides the investigated intervention|}}}]]
| style="text-align:left;" | [[Other explanations for an effect besides the investigated intervention::{{{Other explanations for an effect besides the investigated intervention|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects  
! style="text-align:left; text-indent:3em;" | - Possibility of attention effects  
| style="white-space: pre-wrap;" | [[Possibility of attention effects::{{{Possibility of attention effects|}}}]]
| [[Possibility of attention effects::{{{Possibility of attention effects|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects  
! style="text-align:left; text-indent:3em;" | - Possibility of placebo effects  
| style="white-space: pre-wrap;" | [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]]
| [[Possibility of placebo effects::{{{Possibility of placebo effects|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Other reasons  
! style="text-align:left; text-indent:3em;" | - Other reasons  
| style="white-space: pre-wrap;" | [[Other reasons::{{{Other reasons|}}}]]
| [[Other reasons::{{{Other reasons|}}}]]
|}
|}
==Statistics==
==Statistics==
{| class="wikitable" style="width:75%;"
{| class="wikitable" style="width:100%;"
|-
|-
! width=75% style="text-align:left;" | Correct use of parametric and non-parametric tests  
! width=70% style="text-align:left;" | Correct use of parametric and non-parametric tests {{#info: Testing for normal distribution only necessary if parametric tests are used, NI: use of parametric tests without report of normal distribution testing| note}}
| style="text-align:center;" | [[Correct use of parametric and non-parametric tests::{{{Correct use of parametric and non-parametric tests|}}}]]
| style="text-align:left;" | [[Correct use of parametric and non-parametric tests::{{{Correct use of parametric and non-parametric tests|}}}]]
|-
|-
! style="text-align:left;" | Correction for multiple testing  
! style="text-align:left;" | Correction for multiple testing  
| style="text-align:center;" | [[Correction for multiple testing::{{{Correction for multiple testing|}}}]]
| style="text-align:left;" | [[Correction for multiple testing::{{{Correction for multiple testing|}}}]]
|-
|-
! style="text-align:left;" | Measurement of compliance  
! style="text-align:left;" | Measurement of compliance  
| style="text-align:center;" | [[Measurement of compliance::{{{Measurement of compliance|}}}]]
| style="text-align:left;" | [[Measurement of compliance::{{{Measurement of compliance|}}}]]
|-
! style="text-align:left;" | Blinding reliable
| style="text-align:center;" | [[Blinding reliable::{{{Blinding reliable|}}}]]
|-
! style="text-align:left;" | Check whether blinding (of participants) was successful
| style="text-align:center;" | [[Check whether blinding was successful::{{{Check whether blinding was successful|}}}]]
|-
|-
! style="text-align:left;" | Consistent reporting in numbers (figures, flowchart, abstract, results)
! style="text-align:left;" | Consistent reporting in numbers (figures, flowchart, abstract, results)
| style="text-align:center;" | [[Consistent reporting in numbers::{{{Consistent reporting in numbers|}}}]]
| style="text-align:left;" | [[Consistent reporting in numbers::{{{Consistent reporting in numbers|}}}]]
|-
|-
! style="text-align:left;" | Comprehensive and coherent reporting  
! style="text-align:left;" | Comprehensive and coherent reporting  
| style="text-align:center;" | [[Comprehensive and coherent reporting::{{{Comprehensive and coherent reporting|}}}]]
| style="text-align:left;" | [[Comprehensive and coherent reporting::{{{Comprehensive and coherent reporting|}}}]]
|-
|-
! style="text-align:left;" | Cross-over
! style="text-align:left;" | Cross-over
| style="text-align:center;" | [[Cross-over::{{{Cross-over|}}}]]
| style="text-align:left;" | [[Cross-over::{{{Cross-over|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Sufficient washout period  
! style="text-align:left; text-indent:3em;" | - Sufficient washout period  
| style="text-align:center;" | [[sufficient washout period::{{{sufficient washout period|}}}]]
| style="text-align:left;" | [[sufficient washout period::{{{sufficient washout period|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Tested for carry-over effects  
! style="text-align:left; text-indent:3em;" | - Tested for carry-over effects  
| style="text-align:center;" | [[Tested for carry-over effects::{{{Tested for carry-over effects|}}}]]
| style="text-align:left;" | [[Tested for carry-over effects::{{{Tested for carry-over effects|}}}]]
|-
|-
! style="text-align:left; text-indent:3em;" | - Tested for sequence effects
! style="text-align:left; text-indent:3em;" | - Tested for sequence effects
| style="text-align:center;" | [[Were sequence effects tested::{{{Were sequence effects tested|}}}]]
| style="text-align:left;" | [[Were sequence effects tested::{{{Were sequence effects tested|}}}]]
|}
|}
==Interpretation of results==
==Interpretation of results==
{| class="wikitable" style="width:75%;"
{| class="wikitable" style="width:100%;"
|-
|-
! width=75% style="text-align:left;" | Effect sizes reported (clinical vs. statistical significance)  
! width=70% style="text-align:left;" | Effect sizes reported (clinical vs. statistical significance)  
| style="text-align:center;" | [[Effect sizes reported::{{{Effect sizes reported|}}}]]
| style="text-align:left;" | [[Effect sizes reported::{{{Effect sizes reported|}}}]]
|-
|-
! style="text-align:left;" | Side effects systematically recorded  
! style="text-align:left;" | Side effects systematically recorded  
| style="text-align:center;" | [[Were side effects systematically recorded::{{{Were side effects systematically recorded|}}}]]
| style="text-align:left;" | [[Were side effects systematically recorded::{{{Were side effects systematically recorded|}}}]]
|-
|-
! style="text-align:left;" | Side effects considered in result interpretation
! style="text-align:left;" | Side effects considered in result interpretation
| style="text-align:center;" | [[Side effects taken into account in the interpretation of the results::{{{Side effects taken into account in the interpretation of the results|}}}]]
| style="text-align:left;" | [[Side effects taken into account in the interpretation of the results::{{{Side effects taken into account in the interpretation of the results|}}}]]
|-
|-
! style="text-align:left;" | Ethics votum
! style="text-align:left;" | Ethics votum
| style="text-align:center;" | [[Ethics / CoI / Funding::{{{Ethics / CoI / Funding|}}}]]
| style="text-align:left;" | [[Ethics / CoI / Funding::{{{Ethics / CoI / Funding|}}}]]
|}
|}
</includeonly>
</includeonly>

Latest revision as of 12:09, 6 November 2024

This is the "Further points for assessing the study" template.

It should be called in the following format:

{{Further points for assessing the study
|Samples sufficiently large=
|power analysis performed=
|reasons given for samples=
|Ethnicity mentioned=
|Possibility of attention effects=
|Possibility of placebo effects=
|Other reasons=
|Testing for normal distribution=
|Correct application of statistical=
|Correction for multiple testing=
|Measurement of compliance=
|Blinding reliable=
|Check whether blinding was successful=
|Consistent reporting in numbers=
|Sufficient washout period=
|Tested for carry-over=
|Were sequence effects tested=
|Comprehensive and coherent reporting=
|Were side effects systematically recorded=
|Effect sizes reported=
|Side effects taken into account in the interpretation of the results=
|mono- or multicentric=
|Ethics / CoI / Funding=
}}

Edit the page to see the template text.

Retrieved from "https://camih.med.uni-jena.de/camih/index.php?title=Template:Further_points_for_assessing_the_study&oldid=6377"